Clinical Trial Update: Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigates whether combined antiretroviral therapy can identify sites of persistent HIV infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Combined Antiretroviral Therapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 1 | Status: COMPLETED